Adverse events · proliferative diabetic retinopathy
1 finding from 1 review
BCVA: loss of 15 or more ETDRS letters · proliferative diabetic retinopathy
Centre sparing PRP showed no clear difference in BCVA: loss of 15 or more ETDRS letters compared with full scatter PRP (low certainty).
1 finding from 1 review
BCVA: gain of 15 or more ETDRS letters · proliferative diabetic retinopathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Progression of DR ‐ not reported · proliferative diabetic retinopathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Regression of PDR · proliferative diabetic retinopathy
Centre sparing PRP showed no clear difference in regression of PDR compared with full scatter PRP (low certainty).
1 finding from 1 review
Pain during laser treatment ‐ not reported · proliferative diabetic retinopathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Vision‐related QoL ‐ not reported · proliferative diabetic retinopathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events ‐ not reported · proliferative diabetic retinopathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
BCVA: loss of 15 or more ETDRS letters · people with diabetic retinopathy
Extended targeted PRP showed no clear difference in BCVA: loss of 15 or more ETDRS letters: compared with standard PRP (low certainty).
1 finding from 1 review
BCVA: gain of 15 or more ETDRS letters · people with diabetic retinopathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pain during laser treatment ‐ not reported · proliferative diabetic retinopathy
It is very uncertain whether nd:YAG laser changes pain during laser treatment compared with argon‐green laser (very low certainty).
1 finding from 1 review
Progression of DR ‐ not reported · people with diabetic retinopathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Regression of PDR · people with diabetic retinopathy
Extended targeted PRP showed no clear difference in regression of PDR compared with standard PRP (low certainty).
1 finding from 1 review
Pain during laser treatment ‐ not reported · people with diabetic retinopathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Vision‐related QoL ‐ not reported · people with diabetic retinopathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · people with diabetic retinopathy
It is very uncertain whether extended targeted PRP changes adverse events compared with standard PRP (very low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Vision‐related QoL ‐ not reported · proliferative diabetic retinopathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · proliferative diabetic retinopathy
It is very uncertain whether nd:YAG laser changes adverse events compared with argon‐green laser (very low certainty).
1 finding from 1 review
BCVA: loss of 15 or more ETDRS letters · proliferative diabetic retinopathy
It is very uncertain whether diode laser changes BCVA: loss of 15 or more ETDRS letters compared with argon laser (very low certainty).
1 finding from 1 review
BCVA: gain of 15 or more ETDRS letters · proliferative diabetic retinopathy
It is very uncertain whether diode laser changes BCVA: gain of 15 or more ETDRS letters compared with argon laser (very low certainty).
1 finding from 1 review